New oral antidiabetic drugs. Synthesis and structure-activity relationships
Francia, E.; Marin, A.; Verdejo, F.; Sanchez, M.S.; Morell, J.
Bollettino Chimico Farmaceutico 114(7): 379-392
1975
ISSN/ISBN: 0006-6648 PMID: 1164447 Document Number: 91839
Document emailed within 1 workday
Related Documents
Wang, E.H.; Du, F.D.; Xiang, B.R. 1981: Molecular connectivity studies on quantitative structure-activity of drugs. II. Quantitative structure-activity relationships for leucomycins, lincomycins and clindamycins Yao Xue Xue Bao 16(2): 86-91Kojima, E.; Shirasaka, T.; Machida, M.; Yoshioka, H.; Murakami, K.; Mitsuya, H. 1991: Synthesis and structure-activity relationships of 2',3'-dideoxypurine nucleosides as potential antiretroviral agents Nucleic Acids Symposium Series 25: 91-92
De Clercq, E.; Torrence, P.F. 1981: Structure-activity relationships for interferon induction and inhibition of protein synthesis by polynucleotides Texas Reports on Biology and Medicine 41: 76-83
Prozialeck, W.C.; Weiss, B. 1982: Inhibition of calmodulin by phenothiazines and related drugs: structure-activity relationships Journal of Pharmacology and Experimental Therapeutics 222(3): 509-516
Hansch, C.; Smith, N.; Engle, R.; Wood, H. 1972: Quantitative structure-activity relationships of antineoplastic drugs: nitrosoureas and triazenoimidazoles Cancer ChemoTherapy Reports 56(4): 443-456
Fossa, P.; Boggia, R.; Lo Presti, E.; Mosti, L.; Dorigo, P.; Floreani, M. 1997: Inotropic Agents. Synthesis and Structure-Activity Relationships of new Milrinone Related Camp Pde Iii Inhibitors Farmaco 52(8-9): 523-530
Lattrell, R.; Dürckheimer, W.; Kirrstetter, R.; Limbert, M.; Seibert, G. 1987: Structure-activity relationships in the cefpirome (HR 810) series: synthesis and antibacterial activity of 7 alpha-methoxy and 7 alpha-formylamino analogues of HR 810 Chemioterapia: international journal of the Mediterranean Society of Chemotherapy 6(2 Suppl): 96-97
Mailliet, P.; Segal-Bendirdjian, E.; Kozelka, J.; Barreau, M.; Baudoin, B.; Bissery, M.C.; Gontier, S.; Laoui, A.; Lavelle, F.; Le Pecq, J.B. 1995: Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships Anti-Cancer Drug Design 10(1): 51-73
Panicker, G.K.; Karnad, D.R.; Salvi, V.; Kothari, S. 2012: Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs Journal of the Association of Physicians of India 60: 56-61
Patel, R.B.; Shah, G.F.; Raval, J.D.; Patel, M.R. 1987: Influence of antidiabetic drugs on the activity of nonsteroidal anti-inflammatory drugs in carrageenan paw edema test in the rat Indian Journal of Physiology and Pharmacology 31(4): 289-292
Koivisto, V. 1999: Insulin analogs and new oral antidiabetic drugs Duodecim; Laaketieteellinen Aikakauskirja 115(20): 2197-2202
Mager, H.; Barth, A. 1979: Problems involved in the specification and interpretation of quantitative structure-activity relationships. Part 1: a modified type of structure-activity equations Die Pharmazie 34(9): 557-559
Fabbian, F.; De Giorgi, A.; Monesi, M.; Tiseo, R.; Storari, A.; Mallozzi Menegatti, A.; Pala, M.; Tomasi, F.; Portaluppi, F.; Manfredini, R. 2014: Prescription of oral antidiabetic drugs in K/DIGO chronic kidney disease stage 3 and 4: a single centre report Minerva Urologica e Nefrologica 66(1): 69-75
Jönsson, N.A. 1972: Chemical structure and teratogenic properties. 3. a review of available data on structure-activity relationships and mechanism of action of thalidomide analogues Acta Pharmaceutica Suecica 9(6): 521-542
Panikar, V.; Joshi, S.R.; Deogaonkar, N.; Vadgama, J.; Nasikkar, N.; Kamat, T.; Sheikh, S.; Jain, C.C.; Wagle, T. 2018: Efficacy of SGLT2 Inhibitors as the Fifth Drug in the Management of Type 2 Diabetes Mellitus in Asian Indians not Controlled with at least 4 Oral Antidiabetic Drugs Journal of the Association of Physicians of India 66(12): 46-49
Altomare, C.; Carotti, A.; Cellamare, S.; Carrieri, A.; Ciabatti, R.; Malabarba, A. 1994: Lipophilicity of teicoplanin antibiotics as assessed by reversed phase high-performance liquid chromatography: quantitative structure-property and structure-activity relationships Journal of Pharmacy and Pharmacology 46(12): 994-999
Wu, K.; Tong, Z.S.; Dai, C.S.; Li, L.; Zheng, S.X. 1993: Synthesis and bio-activity of coumarin derivatives and studies on its relationships between activity and lipophilicity Yao Xue Xue Bao 28(4): 266-272
Stanković, S. 2001: X-rays in molecular biophysics: structure-activity relationships and activity of steroid hormones Medicinski Pregled 54(9-10): 413-421
Cechinel Filho, V.; Pinheiro, T.; Nunes, R.J.; Yunes, R.A.; Cruz, A.B.; Moretto, E. 1994: Antibacterial activity of N-phenylmaleimides, N-phenylsuccinimides and related compounds. Structure-activity relationships Farmaco 49(10): 675-677
Richards, R.K. 1980: Structure-activity relationships in the effects of phenacemide analogs on serum creatinine and anticonvulsant activity Archives Internationales de Pharmacodynamie et de Therapie 244(1): 107-112